-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
NovoCure Ltd quarterly/annual Revenues history and growth rate from 2016 to 2023.
- NovoCure Ltd Revenues for the quarter ending September 30, 2024 was $155M, a 21.8% increase year-over-year.
- NovoCure Ltd Revenues for the twelve months ending September 30, 2024 was $578M, a 14.6% increase year-over-year.
- NovoCure Ltd annual Revenues for 2023 was $509M, a 5.3% decline from 2022.
- NovoCure Ltd annual Revenues for 2022 was $538M, a 0.53% increase from 2021.
- NovoCure Ltd annual Revenues for 2021 was $535M, a 8.23% increase from 2020.